Education
About Us
Working with TipRanks
Follow Us
Chemical Industries Far East Ltd. (SG:C05)
SGX:C05
Top Page
Chemical Industries Far East Ltd.
(SGX:C05)
Select Model
Select Model
Rating:46Neutral
Price Target:
S$0.48
▼(-8.65% Downside)
The overall stock score is primarily impacted by the company's declining financial performance and bearish technical indicators. The negative P/E ratio further contributes to a poor valuation score. Despite a strong balance sheet, operational inefficiencies and cash flow challenges are significant concerns.
Positive Factors
Strong Balance Sheet
A strong balance sheet with low leverage provides financial stability and flexibility, allowing the company to navigate operational challenges and invest in growth opportunities.
Strategic Partnerships
Strategic partnerships enhance innovation and product development, enabling the company to meet emerging market demands and maintain competitive advantages.
Focus on Sustainability
Emphasizing sustainability aligns with global trends and regulatory requirements, potentially expanding the customer base and ensuring long-term growth.
Negative Factors
Declining Revenue
Declining revenue indicates potential loss of market share or demand, which can impact long-term growth prospects and financial performance.
Negative Profit Margins
Negative profit margins suggest inefficiencies and cost management issues, which may hinder the company's ability to generate sustainable profits.
Cash Flow Challenges
Negative free cash flow can limit the company's ability to invest in growth and meet financial obligations, affecting long-term financial health.
Chemical Industries Far East Ltd. (C05) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$39.49M
Dividend Yield0.92%
Average Volume (3M)8.50K
Price to Earnings (P/E)―
Beta (1Y)0.08
Revenue Growth-7.45%
EPS Growth-480.22%
CountrySG
Employees150
SectorBasic Materials
Sector Strength58
IndustryChemicals
Share Statistics
EPS (TTM)-0.03
Shares Outstanding75,945,400
10 Day Avg. Volume9,380
30 Day Avg. Volume8,503
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.36
Price to Sales (P/S)0.58
P/FCF Ratio-61.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Chemical Industries Far East Ltd. Business Overview & Revenue Model
Company DescriptionChemical Industries (Far East) Limited, an investment holding company, manufactures and sells chemicals in Singapore and Myanmar. The company operates in two segments, Industrial Chemicals and Properties. It offers sodium hypochlorite, chlorine, hydrochloric acid, and calcium hydroxide for water treatment chemicals and electronics; and distribution and transportation services. The company also manages and rents commercial properties. In addition, it operates as a general merchant, importer, and exporter of chemicals. The company was incorporated in 1962 and is based in Singapore.
How the Company Makes MoneyThe company generates revenue primarily through the sale of its specialty chemicals and industrial products to various sectors. Key revenue streams include direct sales to end-users, distribution partnerships with local and regional suppliers, and long-term contracts with major industrial clients. Additionally, Chemical Industries Far East Ltd. benefits from strategic partnerships with research institutions and technology providers, allowing them to innovate and introduce new products that meet emerging market demands. The company's focus on sustainability and regulatory compliance also attracts clients looking for eco-friendly solutions, further contributing to its revenue growth.
Chemical Industries Far East Ltd. Financial Statement Overview
Summary
Chemical Industries Far East Ltd. faces significant operational challenges, as evidenced by declining revenue and profitability. Despite a strong balance sheet with low leverage, the negative return on equity and cash flow issues highlight areas of concern. The company needs to address its operational inefficiencies to improve its financial health.Income Statement
The income statement shows a concerning trend with declining revenue and profitability. The company experienced a negative revenue growth rate of -1.3% in the latest period, and both EBIT and net profit margins are negative, indicating operational challenges. Historically, the company had positive margins, but recent performance has deteriorated significantly.45
Neutral
Balance Sheet
The balance sheet remains relatively stable with a low debt-to-equity ratio of 0.015, suggesting conservative leverage. However, the return on equity has turned negative, reflecting the company's recent losses. The equity ratio is healthy, indicating a strong equity base relative to assets.65
Positive
Cash Flow
Cash flow analysis reveals mixed results. While operating cash flow is positive, free cash flow remains negative, although it has improved significantly. The operating cash flow to net income ratio is below 1, indicating potential cash flow challenges relative to earnings.50
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.37M | 65.37M | 72.58M | 100.03M | 85.00M | 63.00M |
| Gross Profit | 3.84M | 3.84M | 5.63M | 6.93M | 22.07M | 19.31M |
| EBITDA | -18.32M | -15.09M | 11.73M | 8.91M | 11.06M | 14.08M |
| Net Income | -21.46M | -21.46M | 4.87M | 3.55M | 6.80M | 5.57M |
Balance Sheet | ||||||
| Total Assets | 138.13M | 138.13M | 147.52M | 146.41M | 152.65M | 145.41M |
| Cash, Cash Equivalents and Short-Term Investments | 23.47M | 23.47M | 21.44M | 29.44M | 44.98M | 41.74M |
| Total Debt | 6.71M | 6.71M | 2.60M | 3.59M | 4.69M | 5.53M |
| Total Liabilities | 31.95M | 31.95M | 18.31M | 21.04M | 22.26M | 20.68M |
| Stockholders Equity | 106.18M | 106.18M | 129.21M | 125.37M | 130.39M | 124.74M |
Cash Flow | ||||||
| Free Cash Flow | 518.00K | -621.00K | -7.05M | -14.39M | 4.21M | 12.00M |
| Operating Cash Flow | 10.27M | 9.13M | 4.81M | -8.63M | 6.07M | 14.77M |
| Investing Cash Flow | -14.61M | -9.74M | -11.84M | -5.73M | -1.87M | -2.61M |
| Financing Cash Flow | 2.90M | 3.07M | -1.08M | -1.05M | -990.00K | -2.16M |
Chemical Industries Far East Ltd. Technical Analysis
Negative
0.52
Price Trends
0.52
Negative
0.54
Negative
0.52
Negative
Market Momentum
>-0.01
Positive
35.73
Neutral
33.64
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:C05, the sentiment is Negative. The current price of 0.52 is below the 20-day moving average (MA) of 0.53, below the 50-day MA of 0.52, and above the 200-day MA of 0.52, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 35.73 is Neutral, neither overbought nor oversold. The STOCH value of 33.64 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:C05.
Chemical Industries Far East Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
SG:C05
Chemical Industries Far East Ltd.
0.50
0.02
4.17%
SG:5DS
MegaChem Ltd.
0.43
<0.01
1.19%
SG:A55
Asia Enterprises Holding Ltd.
0.15
0.02
16.41%
SG:BTX
Anchun International Holdings Ltd.
0.43
0.14
46.55%
SG:C8R
Jiutian Chemical Group Limited
0.03
>-0.01
-7.41%
SG:Y8E
Samurai 2K Aerosol Ltd.
0.13
0.07
108.33%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.